Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Ju Hsu

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|February 26, 2008
Factor Xa active site substrate specificity with substrate phage display and computational molecular modelingHung-Ju Hsu, Keng-Chang Tsai, Yi-Kun Sun, et al.
Colloids and Surfaces. B, Biointerfaces|August 9, 2019
Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT)Chun-Yi Wu, Jia-Jia Lin, Wen-Yi Chang, et al.
Mabs|December 12, 2018
Effective binding to protein antigens by antibodies from antibody libraries designed with enhanced protein recognition propensitiesJhih-Wei Jian, Hong-Sen Chen, Yi-Kai Chiu, et al.
Journal of Agricultural and Food Chemistry|June 18, 2015
Discovery of Potent Cysteine-Containing Dipeptide Inhibitors against Tyrosinase: A Comprehensive Investigation of 20 × 20 Dipeptides in Inhibiting Dopachrome FormationTien-Sheng Tseng, Keng-Chang Tsai, Wang-Chuan Chen, et al.
Structure (London, England : 1993)|April 17, 2009
Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous bindersHung-Ju Chang, Hung-Ju Hsu, Chi-Fon Chang, et al.
Structure (London, England : 1993)|November 26, 2013
Loop-sequence features and stability determinants in antibody variable domains by high-throughput experimentsHung-Ju Chang, Jhih-Wei Jian, Hung-Ju Hsu, et al.
Structure (London, England : 1993)|November 26, 2013
Antibody variable domain interface and framework sequence requirements for stability and function by high-throughput experimentsHung-Ju Hsu, Kuo Hao Lee, Jhih-Wei Jian, et al.
Journal of Biomedical Science|November 11, 2025
Technological advancements in antibody-based therapeutics for treatment of diseasesRuei-Min Lu, Hsiao-Ling Chiang, Joyce Pei-Yi Yuan, et al.
Plos One|March 30, 2012
Rationalization and design of the complementarity determining region sequences in an antibody-antigen recognition interfaceChung-Ming Yu, Hung-Pin Peng, Ing-Chien Chen, et al.
Mabs|October 27, 2018
Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft modelsWei-Ying Kuo, Hung-Ju Hsu, Chun-Yi Wu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|February 26, 2008
Factor Xa active site substrate specificity with substrate phage display and computational molecular modelingHung-Ju Hsu, Keng-Chang Tsai, Yi-Kun Sun, et al.
Colloids and Surfaces. B, Biointerfaces|August 9, 2019
Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT)Chun-Yi Wu, Jia-Jia Lin, Wen-Yi Chang, et al.
Mabs|December 12, 2018
Effective binding to protein antigens by antibodies from antibody libraries designed with enhanced protein recognition propensitiesJhih-Wei Jian, Hong-Sen Chen, Yi-Kai Chiu, et al.
Journal of Agricultural and Food Chemistry|June 18, 2015
Discovery of Potent Cysteine-Containing Dipeptide Inhibitors against Tyrosinase: A Comprehensive Investigation of 20 × 20 Dipeptides in Inhibiting Dopachrome FormationTien-Sheng Tseng, Keng-Chang Tsai, Wang-Chuan Chen, et al.
Structure (London, England : 1993)|April 17, 2009
Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous bindersHung-Ju Chang, Hung-Ju Hsu, Chi-Fon Chang, et al.
Structure (London, England : 1993)|November 26, 2013
Loop-sequence features and stability determinants in antibody variable domains by high-throughput experimentsHung-Ju Chang, Jhih-Wei Jian, Hung-Ju Hsu, et al.
Structure (London, England : 1993)|November 26, 2013
Antibody variable domain interface and framework sequence requirements for stability and function by high-throughput experimentsHung-Ju Hsu, Kuo Hao Lee, Jhih-Wei Jian, et al.
Journal of Biomedical Science|November 11, 2025
Technological advancements in antibody-based therapeutics for treatment of diseasesRuei-Min Lu, Hsiao-Ling Chiang, Joyce Pei-Yi Yuan, et al.
Plos One|March 30, 2012
Rationalization and design of the complementarity determining region sequences in an antibody-antigen recognition interfaceChung-Ming Yu, Hung-Pin Peng, Ing-Chien Chen, et al.
Mabs|October 27, 2018
Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft modelsWei-Ying Kuo, Hung-Ju Hsu, Chun-Yi Wu, et al.
Pageof 3